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Background: Depression and B-type natriuretic peptide (BNP) predict adverse outcomes in heart failure (HF), but the joint effect of depression 
and BNP is not known. Depression may lead to a dysregulation of the important balance between sympathetic nervous system activity and BNP 
levels. This investigation determines the combined predictive value of depression and amino-terminal pro-BNP (NT-proBNP) for cardiovascular (CV) 
and all-cause mortality in HF patients.
Methods: Participants in the Cardiovascular Health Study with adjudicated HF (N=295, age=75±6 yrs, 51% women) were evaluated for depression 
(CES-D scale), NT-proBNP (cut-off 190 pg/mL), clinical and echocardiographic measures. Median follow-up was 10.7 yrs.
Results: Depressed HF patients were at elevated risk of CVD mortality (HR=2.07, 95%CI=1.31-3.27) and all-cause mortality (HR=1.49, 
95%CI=1.05-2.11), independent of NT-proBNP, demographic and clinical covariates. Depression was not related to NT-proBNP levels 
(r=0.01,p=0.98). As shown in the Figure, the combined presence of depression and elevated NT-proBNP was highly predictive of CV mortality 
(HR=5.42, 95%CI=2.38-12.36) and remained significant when adjusting for covariates (HR=3.15,CI=1.75-5.69). The joint risk for all-cause mortality 
was 3.7 (CI=2.20-6.37).
Conclusions: Depression and NT-proBNP are independent predictors of CV-related and all-cause 
mortality in HF patients. Depression may therefore add to the risk stratification based on biomarker profiles.
